TY - JOUR T1 - The impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China JF - BMJ Global Health JO - BMJ Global Health DO - 10.1136/bmjgh-2021-007109 VL - 7 IS - 1 SP - e007109 AU - Chenjin Ma AU - Xiangyu Guo AU - Lan Wang AU - Wang Li AU - Shelan Liu AU - Feng Lin AU - Wangli Xu Y1 - 2022/01/01 UR - http://gh.bmj.com/content/7/1/e007109.abstract N2 - Background It has been reported that strict non-pharmaceutical measures can significantly reduce the incidence and mortality of respiratory and intestinal infectious diseases during the COVID-19 pandemic, but there are limited reports on the impact in terms of the rates of zoonotic diseases.Methods We extracted the incidence and mortality data of eight notifiable infectious zoonotic diseases from the website of the National Health Commission of the People’s Republic of China for the period of January 2015 to April 2021.Results First, the overall incidence of zoonotic diseases decreased from 0.3714 per 100 000 in 2015–2019 to 0.2756 in 2020 (25.79% reduction, p<0.001); however, a dramatic increase in activity was seen in 2021 compared with 2020 (0.4478 per 100 000 in 2021, 62.47% increase, p<0.001). Anthrax, brucellosis, leptospirosis and hydatid disease exhibited significant upward trends in 2021. Second, analysed further by stages, the monthly incidence in the routine stage (from May to December 2020) was much higher than that in the emergency stage of the COVID-19 (from January to April 2020) (55.33% increase, p<0.001). We also found that the monthly observed incidence was significantly lower than the predicted incidence of a 10.29% reduction in the emergency stage. Third, no differences were seen in mortality between 2021 and 2020, while a significant decline was found in 2020 compared with the previous 5 years (72.70%, p<0.001).Conclusions Strict containment and feasible suppression strategies during the 2020 period of the COVID-19 pandemic had positive impacts on the overall incidence of zoonotic diseases in China. However, anthrax, brucellosis, leptospirosis and hydatid diseases might increase with the relaxation of non-pharmacological interventions in 2021.Data are available in a public, open access repository. Data are available in a public, open access repository. No additional data were available. ER -